To infect cells we knew #SARSCoV2 relies on ACE2 binding.
But then what?
Today @CellCellPress we've learned about the genes and pathways involved via whole genome #CRISPR knockout screens of lung cellshttps://t.co/iNknBW6Otx @ZDaniloski @nygenome @nevillesanjana @virusninja pic.twitter.com/aM42cvzesA
— Eric Topol (@EricTopol) October 24, 2020
• Genome-wide CRISPR knockout screen identifies host factors for SARS-CoV-2 infection
• Top-ranked genes include vacuolar ATPases, Retromer, Commander and Arp2/3 complex
• Validation using CRISPR knockout, RNA interference and small molecule inhibitors
• Reduced infection via increased cholesterol biosynthesis and sequestration of ACE2
To better understand host-virus genetic dependencies and find potential therapeutic targets for COVID-19, we performed a genome-scale CRISPR loss-of-function screen to identify host factors required for SARS-CoV-2 viral infection of human alveolar epithelial cells. Top-ranked genes cluster into distinct pathways, including the vacuolar ATPase proton pump, Retromer, and Commander complexes. We validate these gene targets using several orthogonal methods such as CRISPR knock-out, RNA interference knock-down, and small-molecule inhibitors. Using single-cell RNA-sequencing, we identify shared transcriptional changes in cholesterol biosynthesis upon loss of top-ranked genes. In addition, given the key role of the ACE2 receptor in the early stages of viral entry, we show that loss of RAB7A reduces viral entry by sequestering the ACE2 receptor inside cells. Overall, this work provides a genome-scale, quantitative resource of the impact of the loss of each host gene on fitness/response to viral infection.
Reprinted for educational purposes and social benefit, not for profit.